» Articles » PMID: 27445566

Invasive Pulmonary Aspergillosis with Disseminated Infection in Immunocompetent Patient

Overview
Journal Can Respir J
Publisher Wiley
Specialty Pulmonary Medicine
Date 2016 Jul 23
PMID 27445566
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive pulmonary aspergillosis (IPA) is a rare pathology with increasing incidence mainly in critical care settings and recently in immunocompetent patients. The mortality of the disease is very high, regardless of an early diagnosis and aggressive treatment. Here, we report a case of a 56 yr old previously healthy woman who was found unconscious at home and admitted to the emergency room with mild respiratory insufficiency. In the first 24 hours she developed an acute respiratory failure with new radiographic infiltrates requiring Intensive Care Unit admission. A severe obstructive pattern with impossibility of ventilation because of bilateral atelectasis was observed, requiring emergent venovenous extracorporeal membrane oxygenator device insertion. Bronchoscopy revealed occlusion of main bronchi, demonstrating by biopsy an invasive infection by Aspergillus fumigatus and A. flavus. Despite an aggressive treatment and vital support the patient had a fatal outcome. The forensic study confirms the diagnosis of IPA but also revealed the presence of disseminated aspergillosis.

Citing Articles

Predictors for Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: A Retrospective Study.

Yuan C, Zhu R, Hu L, Li J Infect Drug Resist. 2025; 18:909-918.

PMID: 39990783 PMC: 11844216. DOI: 10.2147/IDR.S497840.


An immunocompetent lady with invasive aspergillosis presenting as disseminated lesions: a case report.

Sethi S, Arshad A J Med Case Rep. 2024; 18(1):354.

PMID: 39103930 PMC: 11301935. DOI: 10.1186/s13256-024-04579-z.


Severe pulmonary aspergillosis post viral illness in immunocompetent patients: A case series.

Ghassan M, Wissam S Respir Med Case Rep. 2024; 48:101991.

PMID: 38380072 PMC: 10876679. DOI: 10.1016/j.rmcr.2024.101991.


A post-COVID-19 posterior mediastinitis: Case report.

Hoyek N, Ghorayeb J, Daou I, Jamal D, Mahfoud N, Nawfal G SAGE Open Med Case Rep. 2022; 10:2050313X221081386.

PMID: 35251662 PMC: 8891915. DOI: 10.1177/2050313X221081386.


Fulminant Tracheobronchial Aspergillosis in an Apparently Healthy Adult.

Moribuchi H, Sato R, Matsushima S, Tominaga M, Sasaki J, Nakamura M Intern Med. 2020; 59(10):1295-1298.

PMID: 32418954 PMC: 7303448. DOI: 10.2169/internalmedicine.3857-19.


References
1.
Raja N, Singh N . Disseminated invasive aspergillosis in an apparently immunocompetent host. J Microbiol Immunol Infect. 2006; 39(1):73-7. View

2.
Walsh T, Anaissie E, Denning D, Herbrecht R, Kontoyiannis D, Marr K . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(3):327-60. DOI: 10.1086/525258. View

3.
Dai Z, Zhao H, Cai S, Lv Y, Tong W . Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: a single-centre retrospective analysis of 52 subjects. Respirology. 2012; 18(2):323-31. DOI: 10.1111/j.1440-1843.2012.02283.x. View

4.
Xavier M, Pasqualotto A, Sales M, Severo C, Peixoto Camargo J, Severo L . Invasive pulmonary aspergillosis due to a mixed infection caused by Aspergillus flavus and Aspergillus fumigatus. Rev Iberoam Micol. 2008; 25(3):176-8. DOI: 10.1016/s1130-1406(08)70041-x. View

5.
Dutkiewicz R, Hage C . Aspergillus infections in the critically ill. Proc Am Thorac Soc. 2010; 7(3):204-9. DOI: 10.1513/pats.200906-050AL. View